transforming growth factor beta 1
Last updated 2 May 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The TGFB1 gene provides instructions for producing a protein called transforming growth factor beta-1 (TGFβ-1). The TGFβ-1 protein triggers chemical signals that regulate various cell activities inside the cell, including the growth and division (proliferation) of cells, the maturation of cells to carry out specific functions (differentiation), cell movement (motility), and controlled cell death (apoptosis).
Video picks for GenesVideo library
Normal function
The TGFB1 gene provides instructions for producing a protein called transforming growth factor beta-1 (TGFβ-1). The TGFβ-1 protein triggers chemical signals that regulate various cell activities inside the cell, including the growth and division (proliferation) of cells, the maturation of cells to carry out specific functions (differentiation), cell movement (motility), and controlled cell death (apoptosis).
The TGFβ-1 protein is found throughout the body but is particularly abundant in tissues that make up the skeleton, where it helps regulate the formation and growth of bone and cartilage, a tough, flexible tissue that makes up much of the skeleton during early development. TGFβ-1 is also involved in the formation of blood vessels, development of muscle tissue and body fat, wound healing, inflammatory processes in the immune system, and prevention of tumour growth.
Conditions referring to this gene or chromosome
Other names
TGF-beta 1 protein
TGF-beta-1
TGFB
TGFB1_HUMAN
TGFbeta
transforming growth factor, beta 1
Patient picks for Genes

Children's health
Restricted growth
Dwarfism is a medical or genetic condition which causes people to have restricted growth so that they are shorter than average. Specifically, people with dwarfism grow no higher than 4 ft 10 ins (147 cm). It can be due to literally hundreds of different causes, so the term actually includes many different medical conditions. The cause and type of dwarfism will therefore affect the outlook and problems that may be associated with it. The most common condition causing dwarfism is achondroplasia.
by Dr Hayley Willacy, FRCGP

Diet and nutrition
Biotin: do vitamins for hair growth really work?
If you are interested in hair growth supplements, then chances are you've heard of biotin. In recent years, this vitamin has grown in popularity and is widely available in the cosmetic industry. What exactly is biotin, and can it really promote longer, healthier hair?
by Amberley Davis

Heart health and blood vessels
Dilated cardiomyopathy causes: what are the risk factors?
Having dilated cardiomyopathy means that your heart muscle is weakened, which affects how your heart pumps blood around your body. There are a wide range of dilated cardiomyopathy causes, including genetics, other health conditions, alcohol consumption and a poor diet. While we can't control some of these risk factors, we can make positive lifestyle changes to reduce our risk of developing dilated cardiomyopathy.
by Amberley Davis

Treatment and medication
Extended-spectrum beta-lactamases
Extended-spectrum beta-lactamases (ESBLs) have so far only been reported in certain bacteria called Gram-negative bacterial infections.
by Dr Colin Tidy, MRCGP

Treatment and medication
Beta-blockers
Beta-blockers are medicines that are used to treat a variety of conditions. Their full correct name is beta-adrenoceptor blocking medicines (or beta-adrenergic blocking agents), but they are commonly just called beta-blockers.
by Dr Rosalyn Adleman, MRCGP

Drug interactions checker
Can I take Betahistine and Citalopram together?
There are no known significant interactions between betahistine and citalopram. It is generally considered safe to take these two medicines together.
Related patient information and medicines

Patient information leaflet
Acromegaly
Acromegaly is a rare, progressive condition in which you make too much growth hormone. This causes a range of symptoms that develop gradually, often over several years. The most noticeable symptoms are that your hands and feet become larger and features of your face may become more prominent. The cause is usually a small non-cancerous growth.

Patient information leaflet
Thalassaemia
Thalassaemia is an inherited condition affecting the blood. Thalassaemia is an inherited (genetic) condition affecting the blood. Haemoglobin is made out of different parts. The main parts are called alpha chains and beta chains which are put together to make the haemoglobin molecule. In thalassaemia, part of the haemoglobin is faulty - usually.

Patient information leaflet
Vitamin A deficiency
Vitamin ... Foods that contain vitamin A include liver, milk, eggs and fish-liver oils. Another substance called beta carotene (which is found in green leafy and orange/yellow vegetables and fruits) can also be converted by your body to vitamin A. Mild forms of vitamin A deficiency can usually be treated without any long-term problems. Vitamin A.

Patient information leaflet
Diabetic retinopathy
Also, if you have high blood pressure (hypertension) in addition to diabetes, it ... Who develops diabetic retinopathy. Retinopathy is a common complication of diabetes. It is more common in people with type 1 diabetes Type 1 diabetes. Diabetic retinopathy is the most common cause of severe sight impairment in people of working age in the UK. Risk.

Patient information leaflet
Heart attack
A heart attack (myocardial infarction) is usually caused by a blood clot, which stops the blood flowing to a part of your heart muscle. You should call for an ambulance immediately if you develop severe chest pain. If someone has a heart attack, treatment with a clot-busting medicine or an emergency procedure to restore the blood flow through the.

Patient information leaflet
Telogen effluvium
Telogen effluvium (hair loss) is a condition where more than normal amounts of hair fall out. There is a general 'thinning' of the hair. Unlike some other hair and scalp conditions, it is temporary and the hair growth usually recovers. What is telogen effluvium. Telogen effluvium is rapid hair loss that is caused by stress or a change to your.
Further reading and references
- transforming growth factor beta 1; MedlinePlus, National Library of Medicine.
- Eurekah Bioscience Collection: Transforming Growth Factor-β
- Fujio K, Komai T, Inoue M, Morita K, Okamura T, Yamamoto K. Revisiting the regulatory roles of the TGF-beta family of cytokines. Autoimmun Rev. 2016 Sep;15(9):917-22. doi: 10.1016/j.autrev.2016.07.007. Epub 2016 Jul 5.
- Janssens K, ten Dijke P, Ralston SH, Bergmann C, Van Hul W. Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. J Biol Chem. 2003 Feb 28;278(9):7718-24. doi: 10.1074/jbc.M208857200. Epub 2002 Dec 18.
- Janssens K, Vanhoenacker F, Bonduelle M, Verbruggen L, Van Maldergem L, Ralston S, Guanabens N, Migone N, Wientroub S, Divizia MT, Bergmann C, Bennett C, Simsek S, Melancon S, Cundy T, Van Hul W. Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment. J Med Genet. 2006 Jan;43(1):1-11. doi: 10.1136/jmg.2005.033522. Epub 2005 May 13.
- Long J, Liu Z, Wu X, Xu Y, Ge C. Gene expression profile analysis of pancreatic cancer based on microarray data. Mol Med Rep. 2016 May;13(5):3913-9. doi: 10.3892/mmr.2016.5021. Epub 2016 Mar 21.
- Ma X, Chen C, Xiong H, Li Y. Transforming growth factorbeta1 L10P variant plays an active role on the breast cancer susceptibility in Caucasian: evidence from 10,392 cases and 11,697 controls. Breast Cancer Res Treat. 2010 Nov;124(2):453-7. doi: 10.1007/s10549-010-0843-x. Epub 2010 Mar 27.
- Poniatowski LA, Wojdasiewicz P, Gasik R, Szukiewicz D. Transforming growth factor Beta family: insight into the role of growth factors in regulation of fracture healing biology and potential clinical applications. Mediators Inflamm. 2015;2015:137823. doi: 10.1155/2015/137823. Epub 2015 Jan 29.
- Wallace SE, Lachman RS, Mekikian PB, Bui KK, Wilcox WR. Marked phenotypic variability in progressive diaphyseal dysplasia (Camurati-Engelmann disease): report of a four-generation pedigree, identification of a mutation in TGFB1, and review. Am J Med Genet A. 2004 Sep 1;129A(3):235-47. doi: 10.1002/ajmg.a.30148.
- Walton KL, Makanji Y, Chen J, Wilce MC, Chan KL, Robertson DM, Harrison CA. Two distinct regions of latency-associated peptide coordinate stability of the latent transforming growth factor-beta1 complex. J Biol Chem. 2010 May 28;285(22):17029-37. doi: 10.1074/jbc.M110.110288. Epub 2010 Mar 22.
- Zhao L, Hantash BM. TGF-beta1 regulates differentiation of bone marrow mesenchymal stem cells. Vitam Horm. 2011;87:127-41. doi: 10.1016/B978-0-12-386015-6.00042-1.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

